MDWD
MDWD
NASDAQ · Pharmaceuticals

Mediwound Ltd

$16.69
-0.58 (-3.36%)
As of May 9, 2:00 AM ET ·
Financial Highlights (FY 2026)
Revenue
19.28M
Net Income
-27,140,756
Gross Margin
19.2%
Profit Margin
-140.8%
Rev Growth
-13.8%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 19.2% 19.2% 36.4% 36.4%
Operating Margin -149.0% -134.1% 13.9% 16.0%
Profit Margin -140.8% -133.8% 15.0% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 19.28M 22.37M 84.88M 71.76M
Gross Profit 3.70M 4.29M 30.88M 26.11M
Operating Income -28,716,249 -29,989,120 11.80M 11.51M
Net Income -27,140,756 -28,343,792 12.73M 10.88M
Gross Margin 19.2% 19.2% 36.4% 36.4%
Operating Margin -149.0% -134.1% 13.9% 16.0%
Profit Margin -140.8% -133.8% 15.0% 15.2%
Rev Growth -13.8% -13.8% +19.4% +16.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 18.07M 18.07M 126.77M 98.08M
Total Equity 89.84M 89.84M 68.95M 72.24M
D/E Ratio 0.20 0.20 1.84 1.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,920,455 -30,777,944 16.15M 13.06M
Free Cash Flow 13.25M 12.55M